Barbara J Lonsdorf, PHD | |
614 N 3rd Ave, Suite A, Wausau, WI 54401-2913 | |
(715) 848-3031 | |
(715) 848-5008 |
Full Name | Barbara J Lonsdorf |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 614 N 3rd Ave, Wausau, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982614152 | NPI | - | NPPES |
39208000 | Medicaid | WI |
Mailing Address | Practice Location Address |
---|---|
Barbara J Lonsdorf, PHD 1320 Mcindoe St, Wausau, WI 54403-5083 Ph: (715) 848-3031 | Barbara J Lonsdorf, PHD 614 N 3rd Ave, Suite A, Wausau, WI 54401-2913 Ph: (715) 848-3031 |
News Archive
AbGenomics International announced today that it has raised $9.6 million in current financing round.
According to a latest research by Canadian scientists high estrogen levels are associated with an inability to pay attention and learn. Researchers at the Concordia University in Montreal conducted this study to assess the link between estrogen and memory and learning. The study was published in the journal Brain and Cognition.
Interleukin Genetics, Inc. announced today that the Corporate Compliance Staff of the NYSE Amex LLC has granted the Company an extension to meet the Exchange's continued listing standards and become compliant. The Company will remain listed up to June 23, 2010, subject to periodic review by the Exchange staff during the extension period of progress towards the Company's plan to regain compliance.
Based on its investigation into a small number of complaints that the delivery system of the device had separated at the tip of the inner catheter, Cook Medical has initiated a nationwide/global voluntary recall of its Zilver PTX Drug Eluting Peripheral Stent.
Researchers from the US and Australia recently conducted some studies to assess the in vitro antiviral and virucidal (irreversible) activity of astodrimer sodium against SARS-CoV-2.
› Verified 9 days ago